Cancer Health Center
Laryngeal Cancer Treatment - Stage III Laryngeal Cancer
Supraglottis
STANDARD TREATMENT OPTIONS:
- Surgery with or without postoperative radiation therapy, as evidenced in RTOG-7303, for example.[1,2,3,4,5,6]
- Definitive radiation therapy with surgery for salvage of radiation failures.[7]
- Chemotherapy administered concomitantly with radiation therapy can be considered for patients who would require total laryngectomy for control of disease. Laryngectomy would be reserved for patients with less than a 50% response to chemotherapy or who have persistent disease following radiation.[8,9,10,11,12,13]
TREATMENT OPTIONS UNDER CLINICAL EVALUATION:
- Hyperfractionated radiation therapy to improve tumor control rates and diminish late toxicity to normal tissue.[14,15]
- Clinical trials exploring chemotherapy, radiosensitizers, or particle-beam radiation therapy.[16,17,18,19,20]
A meta-analysis of three trials of patients with locally advanced laryngeal carcinomas compared patients who received standard radical surgery plus radiation therapy with patients who received neoadjuvant cisplatin and fluorouracil (5-FU), followed by radiation therapy alone in responders or radical surgery plus radiation therapy in nonresponders.[21] The meta-analysis demonstrated a nonsignificant trend in favor of the control group who received standard radical surgery plus radiation therapy with an absolute negative effect in the chemotherapy arm that reduced survival at 5 years by 6%. The possibility of a slightly decreased survival must be balanced by the retention of the larynx in those patients whose disease was controlled.
- Isotretinoin (i.e., 13-cis-retinoic acid) daily for 1 year to prevent development of second upper aerodigestive tract primary tumors.[22]
Glottis
STANDARD TREATMENT OPTIONS:
- Surgery with or without postoperative radiation therapy, as evidenced in RTOG-7303, for example.[1,2,3,4,5,6,23]
- Definitive radiation therapy with surgery for salvage of radiation failures.[7,24]
- Chemotherapy administered concomitantly with radiation therapy can be considered for patients who would require total laryngectomy for control of disease. Laryngectomy would be reserved for patients with less than a 50% response to chemotherapy or who have persistent disease following radiation.[8,9,10,11,12,13]
TREATMENT OPTIONS UNDER CLINICAL EVALUATION:
- Hyperfractionated radiation therapy to improve tumor control rates and diminish late toxicity to normal tissue.[14,15]
- Clinical trials exploring chemotherapy, radiosensitizers, or particle beam radiation therapy.[16,17,19,20]
A meta-analysis of three trials of patients with locally advanced laryngeal carcinomas compared patients who received standard radical surgery plus radiation therapy with patients who received neoadjuvant cisplatin and fluorouracil, followed by radiation therapy alone in responders or radical surgery plus radiation therapy in nonresponders.[21] The meta-analysis demonstrated a nonsignificant trend in favor of the control group who received standard radical surgery plus radiation therapy with an absolute negative effect in the chemotherapy arm that reduced survival at 5 years by 6%. The possibility of a slightly decreased survival must be balanced by the retention of the larynx in those patients whose disease was controlled.
- Isotretinoin daily for 1 year to prevent development of second upper aerodigestive tract primary tumors.[22]
WebMD Public Information from the National Cancer Institute
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER
Laryngeal Cancer Treatment Topics
Microscopic particles called “nanoshells” are injected into cancer patients’ bloodstream to help doctors track and destroy tumors.
